TrialJMIR formative research2026

Supporting the Primary Outcomes of the Mirai Trial for the Adjunctive Digital Therapeutic Rejoyn (CT-152) in the Treatment of Major Depressive Disorder: Meaningful Change Analysis in the Montgomery-Åsberg Depression Rating Scale.

Stacie Hudgens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.